B-cell precursor acute lymphoblastic leukemia (BCP-ALL) with chromosome translocations like gene rearrangement (KMT2A-r) and fusion gene have been recognized as crucial drivers in both BCP-ALL leukemogenesis and treatment management. Standard diagnostic protocols for proliferative diseases of the hematopoietic system, like KMT2A-r-ALL, are genetically based and strongly molecularly oriented. Therefore, an efficient diagnostic procedure requires not only experienced and multidisciplinary laboratory staff but also considerable instrumentation and material costs.
View Article and Find Full Text PDF